Syncope as a dominant symptom of pulmonary embolism - a case report

  • Marko B Baralic Klinicki centar Srbije, Klinika za nefrologiju
  • Javorka Mitić Klinika za pulmologiju, Klinički centar Srbije, Beograd, Srbija
  • Nataša Đurđević Clinic for Pulmonary Dieseases, Clinical center of Serbia, Belgrade, Serbia
  • Jelena Janković Clinic for Pulmonary Dieseases, Clinical center of Serbia, Belgrade, Serbia
  • Radomir Vešović Clinic for Thoracic Surgery, Clinical center of Serbia, Belgrade, Serbia
  • Elena Jordanova Clinic for Internal Medicine, Clinical Hospital Center Zemun, Belgrade, Serbia
  • Dejan Tabaković Clinic for Ortopedic Surgery and Traumatology, Clinical center of Serbia, Belgrade, Serbia
  • Radmila Janković School of Medicine, University of belgrade, Institute of Pathology

Abstract


Abstract

Pulmonary embolism (PE) and deep vein thrombosis (DVT) may be an associated clinical syndrome that results from a single entity which is venous thrombo-embolism (VTE).

            In most patients, pulmonary embolism is manifested by a specific triad of symptoms in the form of dyspnea, pleurodynia and tachycardia, while syncope is rare, with an incidence of 6% in all patients. Since syncope with mild dyspnoea was the dominant symptom in our patient, PE was difficult to suspect, which is why additional diagnostics were performed in the form of Doppler ultrasonography of the lower extremities and multislice angiography of the pulmonary artery, which detected the disease and confirmed the diagnosis.

Even though it is a common clinical symptom,  syncope is most often associated with neurological or cardiac events, but it is still a crossroad of various internal diseases because it can also be presented in lung diseases.

 

Keywords: sincopa, embolism, thrombosis

Author Biography

Marko B Baralic, Klinicki centar Srbije, Klinika za nefrologiju
Dr med. specijalista interne medicine

References

1. Effectiveness of a diagnostic algorithm combining clinical probability, D-dimer testing, and computed tomography in patients with suspected pulmonary embolism in emergency department. Galipienzo J, Garcia de Tena J, Flores J, Alvarez C, Garcia-Avello A, Arribas I.Rom J Intern Med. 2012 Jul-Sep;50(3):195-202.
2. A Silent Fatal Presentation of Pulmonary Embolism: Reflection and Discussion.
Zhang Q, Abideen ZU, Shan KS, Yoon T, Farooq M.Cureus. 2020 Jun 24;12(6):e8813. doi:10.7759/cureus.8813.
3. Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study. Lin WC, Weng MT, Tung CC, Chang YT, Leong YL, Wang YT, Wang HY, Wong JM, Wei SC.J Transl Med. 2019 Dec 12;17(1):414. doi: 10.1186/s12967-019-02164-3.

4. Is stand-alone D-dimer testing safe to rule out acute pulmonary embolism? van Es N, van der Hulle T, Büller HR, Klok FA, Huisman MV, Galipienzo J, Di Nisio M.J Thromb Haemost. 2017 Feb;15(2):323-328. doi: 10.1111/jth.13574. Epub 2016 Dec 24.PMID:27873439


5. Condliffe R, Kiely DG, Gibbs JS, Corris PA, Peacock AJ, Jenkins DP, Goldsmith K, Coghlan JG, Pepke-Zaba J. Prognostic and aetiological factors in chronic thromboembolic pulmonary hypertension. Eur Respir J 2009;33(2):332–338.
6. Yan Z, Ip IK, Raja AS, et al. Yield of CT pulmonary angiography in the emergency department when providers override evidence-based clinical decision support. Radiology. 2017;282:717-25
7. van Es N, van der Hulle T, van Es J, et al. Wells rule and D-dimer testing to rule out pulmonary embolism: a systematic review and individualpatient data meta-analysis. Ann Intern Med 2016; 165:253-61.
8. Mos ICM, Douma RA, Erkens PMG, Kruip MJHA, Hovens MM, van Houten AA, Hofstee HMA, Kooiman J, Klok FA, Büller HR, Kamphuisen PW, Huisman M V. Diagnostic outcome management study in patients with clinically suspected recurrent acute pulmonary embolism with a structured algorithm. Thromb Res Elsevier Ltd; 2014; 133: 1039–44.
9. Rali PM, Criner GJ. Submassive pulmonary embolism. Am J Respir Crit Care Med 2018. https://doi.org/10.1164/rccm.201711-2302CI.
10. Deitelzweig SB, Lin J, Johnson BH, et al. Venous thromboembolism in the US: does race matter? J Thromb Thrombolysis 2011. https://doi.org/10.1007/ s11239-010-0503-3.
11. Connors JM. Thrombophilia testing and venous thrombosis. N Engl J Med 2017. https://doi.org/10.1056/NEJMra1700365.
12. Kroep S, Chuang L-H, Cohen A, et al. The impact of co-morbidity on the disease burden of VTE. J Thromb Thrombolysis 2018. https://doi.org/10.1007/s11239- 018-1732-0.
Published
2020/12/22
Section
Case report